Michael Kreuter

Michael Kreuter

UNVERIFIED PROFILE

Are you Michael Kreuter?   Register this Author

Register author
Michael Kreuter

Michael Kreuter

Publications by authors named "Michael Kreuter"

Are you Michael Kreuter?   Register this Author

100Publications

2680Reads

10Profile Views

Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis.

Chest 2019 Oct 29;156(4):706-714. Epub 2019 Apr 29.

Department of Respiratory Medicine, Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard University Lyon 1, UMR754, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2019.04.015DOI Listing
October 2019

The therapy of idiopathic pulmonary fibrosis: what is next?

Eur Respir Rev 2019 Sep 4;28(153). Epub 2019 Sep 4.

Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany

View Article

Download full-text PDF

Source
http://err.ersjournals.com/lookup/doi/10.1183/16000617.0021-
Publisher Site
http://dx.doi.org/10.1183/16000617.0021-2019DOI Listing
September 2019

[New ways in the treatment of SSc-ILD: what makes sense?]

Z Rheumatol 2019 Sep 4. Epub 2019 Sep 4.

Department of Rheumatology, Oslo University Hospital, Oslo, Norwegen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00393-019-00704-2DOI Listing
September 2019

Concomitant Medications and Clinical Outcomes in Idiopathic Pulmonary Fibrosis.

Eur Respir J 2019 Sep 19. Epub 2019 Sep 19.

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01188-2019DOI Listing
September 2019

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design.

Adv Ther 2019 Sep 29. Epub 2019 Sep 29.

Department of Respiratory Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-019-01093-3DOI Listing
September 2019

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.

Lancet Respir Med 2019 Sep 27. Epub 2019 Sep 27.

National Reference Coordinating Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Lyon, France; Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30341-8DOI Listing
September 2019

Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.

Curr Med Res Opin 2019 Aug 2:1-10. Epub 2019 Aug 2.

i Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Claude Bernard University Lyon 1 , Lyon , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2019.1647040DOI Listing
August 2019

Antwort.

Authors:
Michael Kreuter

Pneumologie 2019 Aug 14;73(8):462. Epub 2019 Aug 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0970-6200DOI Listing
August 2019

Digital Lung Auscultation: Will Early Diagnosis of Fibrotic Interstitial Lung Disease Become a Reality?

Am J Respir Crit Care Med 2019 Jul;200(2):261-263

1 Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201902-0306LEDOI Listing
July 2019

Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study.

Ann Am Thorac Soc 2019 Jul 31. Epub 2019 Jul 31.

Columbia University, Divison of Pulmonary, Allergy, and Critical Care Medicine, New York, New York, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1513/AnnalsATS.201903-198RLDOI Listing
July 2019

Can monocytes predict prognosis of idiopathic pulmonary fibrosis?

Lancet Respir Med 2019 Jun 29;7(6):467-469. Epub 2019 Mar 29.

National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(19)30050-5DOI Listing
June 2019

Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.

Respir Med 2019 Jun 22;152:25-31. Epub 2019 Apr 22.

Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Ingolstaedter Landstraße 1, 85764, Neuherberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2019.04.009DOI Listing
June 2019

Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!

Eur Respir J 2019 May 9;53(5). Epub 2019 May 9.

Regional Referral Centre for Rare Lung Diseases, University Hospital "Policlinico", Dept of Clinical and Experimental Medicine, University of Catania, Catania, Italy

View Article

Download full-text PDF

Source
http://erj.ersjournals.com/lookup/doi/10.1183/13993003.00615
Publisher Site
http://dx.doi.org/10.1183/13993003.00615-2019DOI Listing
May 2019

The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis.

Eur Respir J 2019 May 23;53(5). Epub 2019 May 23.

Reference Centre for Rare Pulmonary Diseases, Université Paris Diderot, Inserm U1152, Laboratoire d'Excellence Inflamex, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Service de Pneumologie A, Département Hospitalo-Universitaire FIRE, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00539-2019DOI Listing
May 2019

Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials.

Respir Res 2019 Apr 11;20(1):71. Epub 2019 Apr 11.

Università Cattolica del Sacro Cuore, Fondazione Policlinico A. Gemelli, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-019-1037-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458653PMC
April 2019

The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study.

Eur Respir J 2019 Mar 7;53(3). Epub 2019 Mar 7.

Regional Referral Centre for Rare Lung Diseases, University Hospital "Policlinico", Dept of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01587-2018DOI Listing
March 2019

Utility of Anti-DSF70 Antibodies to Predict Connective Tissue Disease in Patients Originally Presenting with Idiopathic Interstitial Pneumonia.

Respiration 2019 29;98(1):29-37. Epub 2019 Mar 29.

Center for Interstitial and Rare Lung Diseases, Department of Pneumology, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000496483DOI Listing
March 2019

Disseminated Mycosis by Arthrocladium fulminans Jeopardizing a Patient with GATA2 Deficiency.

Respiration 2019 29;97(5):472-475. Epub 2019 Mar 29.

Center for Interstitial and Rare Lung Diseases, Thoraxklinik at University of Heidelberg, Heidelberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000493429DOI Listing
March 2019

Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

Lancet Respir Med 2019 Jan 14;7(1):60-68. Epub 2018 Sep 14.

Center for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; German Center for Lung Research, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22132600183033
Publisher Site
http://dx.doi.org/10.1016/S2213-2600(18)30339-4DOI Listing
January 2019

C-proSP-B: A Possible Biomarker for Pulmonary Diseases?

Respiration 2018 15;96(2):117-126. Epub 2018 May 15.

Department of Pneumology and Critical Care Medicine, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488245DOI Listing
December 2018

Breathlessness and Restrictive Lung Disease: An Important Diabetes-Related Feature in Patients with Type 2 Diabetes.

Respiration 2018 6;96(1):29-40. Epub 2018 Jun 6.

Department of Endocrinology, Diabetology, and Clinical Chemistry, Internal Medicine I, University Hospital of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000488909DOI Listing
December 2018

Nintedanib in Idiopathic Pulmonary Fibrosis: Practical Management Recommendations for Potential Adverse Events.

Respiration 2019 13;97(2):173-184. Epub 2018 Dec 13.

Department of Pulmonary Disease, Erasmus Medical Centre, University Hospital Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000495046DOI Listing
December 2018

Transbronchial Cryobiopsies for Diagnosing Interstitial Lung Disease: Real-Life Experience from a Tertiary Referral Center for Interstitial Lung Disease.

Respiration 2019 14;97(4):348-354. Epub 2018 Dec 14.

Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000493428DOI Listing
December 2018

Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases.

Eur Respir Rev 2018 Dec 21;27(150). Epub 2018 Dec 21.

Dept of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://err.ersjournals.com/lookup/doi/10.1183/16000617.0078-
Publisher Site
http://dx.doi.org/10.1183/16000617.0078-2018DOI Listing
December 2018

[Health Science Research with Primary Care Routine Data From Electronic Patient Records: the BeoNet Registry].

Gesundheitswesen 2018 Nov 11;80(11):1026-1034. Epub 2017 Jul 11.

Klinik für Pneumologie, Medizinische Hochschule Hannover, Hannover.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-108544DOI Listing
November 2018

Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Respiration 2018;95(5):301-309. Epub 2018 Feb 28.

Centre for Interstitial and Rare Lung Diseases, Department of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000485933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985741PMC
October 2018

Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.

Am J Respir Crit Care Med 2018 10;198(8):1105-1106

5 University Hospitals Leuven Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201806-1116LEDOI Listing
October 2018

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies.

Respiration 2018;96(6):571-587. Epub 2018 Oct 11.

Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg and Translational Lung Research Center Heidelberg, member of the German Center for Lung Research, Heidelberg, Germany.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/492336
Publisher Site
http://dx.doi.org/10.1159/000492336DOI Listing
October 2018

Interstitial lung diseases: course report.

Breathe (Sheff) 2018 Sep;14(3):184-185

Pneumology and Allergology Dept, Nicolae Testemitanu State Medical and Pharmaceutical University, Chisinau, Republic of Moldova.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/20734735.019718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118874PMC
September 2018

Should Patients With Interstitial Lung Disease Be Seen by Experts?

Chest 2018 09;154(3):713-714

Clinica di Malattie del Apparato Respiratorio, Università degli Studi di Padova, Padova, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00123692183096
Publisher Site
http://dx.doi.org/10.1016/j.chest.2018.05.044DOI Listing
September 2018

Gazing into the crystal ball: can treatment response be predicted in IPF?

Lancet Respir Med 2018 08 29;6(8):570-572. Epub 2018 Jun 29.

NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(18)30234-0DOI Listing
August 2018

Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis.

Respiration 2018;96(4):314-322. Epub 2018 Jul 19.

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489668DOI Listing
July 2018

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: the heart burn in patients with IPF can no longer be silent.

Eur Respir J 2018 06 21;51(6). Epub 2018 Jun 21.

Center for Interstitial Lung Diseases, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00921-2018DOI Listing
June 2018

Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.

Respir Res 2018 05 25;19(1):101. Epub 2018 May 25.

Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Ingolstaedter Landstrasse 1, 85764, Neuherberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-018-0808-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970441PMC
May 2018

Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.

Respir Res 2018 04 25;19(1):73. Epub 2018 Apr 25.

Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Roentgenstrasse 1, 69126, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12931-018-0769-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918773PMC
April 2018

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Respiration 2017 12;93(6):415-423. Epub 2017 Apr 12.

Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000468546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452370PMC
March 2018

Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions.

Eur Respir Rev 2018 Mar 7;27(147). Epub 2018 Feb 7.

University of Heidelberg and Center for Interstitial and Rare Lung Disease, Division of Respiratory Medicine, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0076-2017DOI Listing
March 2018

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.

Am J Respir Crit Care Med 2018 02;197(3):356-363

10 Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201706-1301OCDOI Listing
February 2018

Patients with IPF and lung cancer: diagnosis and management.

Lancet Respir Med 2018 02 11;6(2):86-88. Epub 2017 Dec 11.

First Academic Department of Pneumonology, Hospital for Diseases of the Chest, "Sotiria", Medical School, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(17)30478-2DOI Listing
February 2018

German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.

Pneumologie 2018 Feb 16;72(2):155-168. Epub 2018 Jan 16.

Schwerpunkt interstitielle und seltene Lungenkrankheiten, Ruhrlandklinik, Universitätsklinikum Essen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-123035DOI Listing
February 2018

Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.

Respiration 2016 1;91(6):497-502. Epub 2016 Jun 1.

LungClinic Grosshansdorf, Pulmonology, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000446607DOI Listing
September 2017

Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Respiration 2016 28;92(1):25-33. Epub 2016 Jun 28.

Radiology Unit, Department of Radiological Functions, x2018;Guglielmo da Saliceto' Hospital, Piacenza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000447430DOI Listing
September 2017

Antifibrotic drugs as treatment of nonidiopathic pulmonary fibrosis interstitial pneumonias: the time is now (?).

Curr Opin Pulm Med 2017 09;23(5):418-425

aCenter for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg bMember of the German Center for Lung Research cDepartment of Internal Medicine V, Comprehensive Pneumology Center, Asklepios Fachkliniken, University of Munich, Munich, Bavaria, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0000000000000408DOI Listing
September 2017

The threat in chronic lung diseases: acute exacerbations.

Eur Respir Rev 2017 Sep 27;26(145). Epub 2017 Sep 27.

National Reference Center for Rare Pulmonary Diseases, Dept of Respiratory Medicine, Louis Pradel Hospital, Claude Bernard University Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/16000617.0075-2017DOI Listing
September 2017

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Pneumologie 2017 Jul 30;71(7):460-474. Epub 2017 May 30.

Schwerpunkt interstitielle und seltene Lungenkrankheiten, Ruhrlandklinik, Universitätsklinikum Essen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-106160DOI Listing
July 2017

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Lancet Respir Med 2017 07;5(7):591-598

Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany; Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(17)30219-9DOI Listing
July 2017

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Pneumologie 2017 07 5;71(7):474. Epub 2017 Jul 5.

Schwerpunkt interstitielle und seltene Lungenkrankheiten, Ruhrlandklinik, Universitätsklinikum Essen.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0043-115504DOI Listing
July 2017

Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.

BMC Pulm Med 2017 Jul 25;17(1):104. Epub 2017 Jul 25.

Pulmonary Research Institute at LungenClinic Grosshansdorf, Woehrendamm 80, 22927, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12890-017-0444-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526311PMC
July 2017

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.

Thorax 2017 02 5;72(2):148-153. Epub 2016 Oct 5.

Department of Medicine, Pathology & Molecular Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2016-208819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5284334PMC
February 2017

The yin and yang of idiopathic pulmonary fibrosis.

Eur Respir J 2017 02 23;49(2). Epub 2017 Feb 23.

Dept of Pulmonary Medicine and National Reference Center for Rare Pulmonary Diseases, Competence Center for Pulmonary Arterial Hypertension, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02316-2016DOI Listing
February 2017

Regional Lung Ventilation Analysis Using Temporally Resolved Magnetic Resonance Imaging.

J Comput Assist Tomogr 2016 Nov/Dec;40(6):899-906

From the *Junior Group Medical Image Computing and †Division of Medical Physics in Radiology, DKFZ, Heidelberg, Germany; ‡Joint Department of Physics at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom; §Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at Heidelberg University, Heidelberg, Germany; ∥Department of Pneumology, luliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; ¶Department of Diagnostic and of Interventional Radiology Heidelberg University, Heidelberg; #Department of Computational Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg; **Department of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik at Heidelberg University Hospital; ††Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg; ‡‡Institute of Clinical Radiology, Munich; §§Comprehensive Pneumology Center Munich (CPC-M), member of the German Center for Lung Research (DZL); and ∥∥Division of Radiology, DKFZ, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000450DOI Listing
January 2017

Screening for Helicobacter pylori in Idiopathic Pulmonary Fibrosis Lung Biopsies.

Respiration 2016 9;91(1):3-8. Epub 2015 Dec 9.

Centre for Interstitial and Rare Lung Diseases, Department of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000442449DOI Listing
October 2016

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives.

Biomed Res Int 2015 8;2015:329481. Epub 2015 Dec 8.

Medical University Clinic, Canton Hospital Baselland and University of Basel, 4410 Liestal, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/329481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686637PMC
October 2016

Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Biomed Res Int 2015 10;2015:123876. Epub 2015 Nov 10.

Medical Clinic II, University Hospital Giessen, Universities of Giessen and Marburg Lung Centre (UGMLC), Member of the German Centre for Lung Research (DZL), 35392 Giessen, Germany ; Medical Clinic V (Pneumology), Cardiothoracic Centre, Campus Fulda, University Medicine Marburg, 36043 Fulda, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/123876DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657073PMC
September 2016

Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

PLoS One 2016 29;11(3):e0151425. Epub 2016 Mar 29.

Centre for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151425PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811578PMC
September 2016

Interstitial lung diseases: course report.

Breathe (Sheff) 2016 Sep;12(3):213-215

Pulmonology, Critical Care and Sleep Medicine, B P Koirala Institute of Health Sciences, Dharan, Nepal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/20734735.011516DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298150PMC
September 2016

Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.

Eur Respir J 2016 06 21;47(6):1776-84. Epub 2016 Apr 21.

National Institute for Health Research Biomedical Research Unit, Royal Brompton Hospital and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.02087-2015DOI Listing
June 2016

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.

Lancet Respir Med 2016 05 31;4(5):381-9. Epub 2016 Mar 31.

Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(16)00067-9DOI Listing
May 2016

Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT).

PLoS One 2015 25;10(6):e0130653. Epub 2015 Jun 25.

Translational Lung Research Centre (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany; Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0130653PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482435PMC
April 2016

Optical coherence tomography detects structural abnormalities of the nasal mucosa in patients with cystic fibrosis.

J Cyst Fibros 2016 Mar 23;15(2):216-22. Epub 2015 Jul 23.

Translational Lung Research Centre Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany; Department of Translational Pulmonology, University Hospital Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2015.07.003DOI Listing
March 2016

An Important Step Forward, but Still a Way to Go.

Am J Respir Crit Care Med 2016 Feb;193(3):340-1

6 Canton Hospital Baselland Basel, Switzerland and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.201509-1763LEDOI Listing
February 2016

Pleuroparenchymal fibroelastosis in association with carcinomas.

Respirology 2016 Jan 13;21(1):191-4. Epub 2015 Oct 13.

Department of Pneumology and Respiratory Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/resp.12654DOI Listing
January 2016

T2 mapping of CT remodelling patterns in interstitial lung disease.

Eur Radiol 2015 Nov 3;25(11):3167-74. Epub 2015 Jun 3.

Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at Heidelberg University Hospital, Amalienstr. 5, 69126, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-015-3751-yDOI Listing
November 2015

IPF, comorbidities and management implications.

Sarcoidosis Vasc Diffuse Lung Dis 2015 Aug 3;32 Suppl 1:17-23. Epub 2015 Aug 3.

Regional Centre for Rare Pulmonary Diseases, Department of Clinical and Experimental Medicine, University of Catania, Italy.

View Article

Download full-text PDF

Source
August 2015

IPF, comorbidities and management implications: Patient case 1.

Authors:
Michael Kreuter

Sarcoidosis Vasc Diffuse Lung Dis 2015 Aug 3;32 Suppl 1:24-5. Epub 2015 Aug 3.

Centre for Rare and Interstitial Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, and Translational Lung Research Center Heidelberg (TLRC), Member of the German Center for Lung Research (DZL), Germany.

View Article

Download full-text PDF

Source
August 2015

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry.

BMJ Open Respir Res 2014 3;1(1):e000010. Epub 2014 Jan 3.

Medical Faculty , Institute for Clinical Pharmacology, Technical University , Dresden , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjresp-2013-000010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212719PMC
December 2014